Outcomes of stage II endometrial cancer: The UPMC Hillman Cancer Center experience.

[1]  D. Beyer,et al.  An analysis of appropriate delivery of postoperative radiation therapy for endometrial cancer using the RAND/UCLA Appropriateness Method: Executive summary , 2015, Advances in radiation oncology.

[2]  P. Grigsby,et al.  Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control? , 2015, Brachytherapy.

[3]  P. Rose,et al.  Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study. , 2015, Gynecologic oncology.

[4]  J. W. Kim,et al.  1A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial , 2014 .

[5]  A. Gadducci,et al.  Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study). , 2014, Gynecologic oncology.

[6]  B. Erickson,et al.  The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. , 2014, Practical radiation oncology.

[7]  F Landoni,et al.  Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  Yoh Watanabe,et al.  Evaluation of Parametrial Spread in Endometrial Carcinoma , 2010, Obstetrics and gynecology.

[9]  S. Pecorelli.  Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .

[10]  D. Kushner,et al.  Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma. , 2009, Gynecologic oncology.

[11]  P. Schiff,et al.  Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation. , 2009, American journal of obstetrics and gynecology.

[12]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[13]  T. Whelan,et al.  Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis , 2009, The Lancet.

[14]  P. Maisonneuve,et al.  Carcinoma of the Corpus Uteri , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[15]  J. Chan,et al.  Therapeutic role of lymph node resection in endometrioid corpus cancer , 2006, Cancer.

[16]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .

[17]  J. Nicklin,et al.  Postoperative vaginal vault brachytherapy for node-negative Stage II (occult) endometrial carcinoma. , 2001, Gynecologic oncology.

[18]  F. Moser,et al.  Parametrial spread in patients with endometrial carcinoma undergoing radical hysterectomy. , 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[19]  A. Mundt,et al.  Surgery and postoperative radiation therapy in stage II endometrial carcinoma. , 1999, American journal of clinical oncology.

[20]  I. Konishi,et al.  Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters. , 1996, Gynecologic oncology.

[21]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[22]  B. Rungruang,et al.  Comprehensive surgical staging for endometrial cancer. , 2012, Reviews in obstetrics & gynecology.

[23]  H. Kuramoto,et al.  Parametrial spread is a prognostic factor in endometrial carcinoma. , 2003, European journal of gynaecological oncology.